ENHANCER, CIRCULATOR

The contract solicits ten units of the RESQPOD CIRCULATORY ENHANCER, a medical device designed to improve blood circulation by applying controlled pressure through a facemask sealed over the nose and mouth, specifically targeting states of low blood flow. The item is identified by NSN 6515-01-696-7098 and falls under NAICS code 339112 for medical equipment manufacturing. Delivery is required within 20 days after order placement to North Little Rock, Arkansas, 72199-9769, under FOB Destination terms, with inspection and acceptance occurring at the destination per FAR 52.246-2. The product must meet stringent DLA packaging and marking standards, conforming to Medical Marking Standard No. 1 (MMS No. 1) which supersedes MIL-STD-129, and adhere to RP001 packaging requirements with commercial unit and shipping containers; each unit must be sealed and labeled with QUP code 001, pack code U, and special marking code ZZ. A 48-month non-extendable shelf life applies under RS021 for TYPE I (CODE R) items, and non-accepted supplies must have all government identification removed as per RQ011. Technical and quality requirements are defined by the DLA Master List using R and I identifiers. The contract incorporates numerous FAR and DFARS clauses, including cybersecurity compliance under NIST SP 800-171, Buy American Act and Berry Amendment restrictions with a $150,000 threshold, prohibitions on trafficking in persons, hazardous material identification, whistleblower protections, and requirements for former DoD official compensation disclosure. Offerors must be registered in SAM, comply with electronic invoicing via WAWF, and submit both invoice and receiving report together or separately unless an exception applies. The solicitation is not a small business set-aside, but contractors must represent their small business status, including WOSB, EDwOSB, and joint venture affiliations, and update these representations in SAM. Pricing data requirements under DFARS 252.215-7994 apply, and offers based on non-domestic materials require disclosure. All proposals must be submitted by close of business on June 2, 2026, to the DLA Troop Support Medical Supply Chain, with payment and administrative